Scientific Reports · 2019 · 28 citations · 27 references
Life SciencesEndocrinologyPharmacologyAnimal PhysiologyMetabolic PhysiologyMetabolic RegulationCholesterol MetabolismInsulin ResistanceInsulin Signaling In MetabolismLipid MetabolismLipid-lowering TherapyMetabolic DisordersAnimal Model PharmacologyCholesterol-lowering EffectsImpaired Glucose ToleranceInsulin PhysiologyInsulin Receptor SignalingInsulin SignalingLipid Metabolism EffectsMuscle Tissue Response
Statins are first-line therapy drugs for cholesterol lowering. While they are highly effective at lowering cholesterol, they have propensity to induce hyperglycemia in patients. Only limited studies have been reported which studied the impact of statins on (a) whether they can worsen glucose tolerance in a high sucrose fed animal model and (b) if so, what could be the molecular mechanism. We designed studies using high sucrose fed animals to explore the above questions. The high sucrose fed animals were treated with atorvastatin and simvastatin, the two most prescribed statins. We examined the effects of statins on hyperglycemia, glucose tolerance, fatty acid accumulation and insulin signaling. We found that chronic treatment with atorvastatin made the animals hyperglycemic and glucose intolerant in comparison with diet alone. Treatment with both statins lead to fatty acid accumulation and inhibition of insulin signaling in the muscle tissue at multiple points in the pathway.
27
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
James Shepherd, Stuart M. Cobbe, Ian Ford et al. · New England Journal of Medicine · 1995 · 7.5K citations · Full text